Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

March's Billion-Dollar Healthcare Deals Signal More To Come No Photo Available

Yeji Jesse Lee

A smattering of billion-dollar M&A transactions could be the kickoff of an exciting period for dealmaking.

3 Healthcare Decisions You May Have Missed This Week No Photo Available

Mark Payne

A proposed class of HIV and AIDS patients is dropping their disability bias lawsuit, the Third Circuit on a COVID-era fraudster senten... (more story)

The Uncertain Impact Of Medicare Advantage Scrutiny No Photo Available

Yeji Jesse Lee

The federal government's scrutiny of long-recognized concerns about the Medicare Advantage industry is heating up. Experts are watchin... (more story)